Marked IgE elevation and eosinophilia in a COPD patient ultimately diagnosed with mycobacterium intracellulare pulmonary disease
- 17 July 2026
- journal article
- case report
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 116 (3) , 117564
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and ProspectsClinical Infectious Diseases, 2024
- World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2024
- Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycosesEuropean Respiratory Journal, 2024
- Tuberculosis manifesting with significant peripheral eosinophilia: A case report and review of literatureClinical Case Reports, 2023
- IgE is associated with exacerbations and lung function decline in COPDRespiratory Research, 2022
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineEuropean Respiratory Journal, 2020
- An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammationRespiratory Research, 2017
- Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adultsMedical Mycology, 2013
- Allergic Bronchopulmonary AspergillosisChest, 2009